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Rheumatoid arthritis (RA) is the most common sys-
temic connective tissue disease. Signs of systemic in-
flammation include constitutional features (e.g. pro-
found fatigue, influenza-like symptoms, fever, sweats
and weight loss) and extra-articular manifestations
(ExRA). The most frequent of such manifestations, the
subcutaneous rheumatoid nodule, has been reported in
up to one third of patients with RA. Severe ExRA ma -
nifestations (e.g. vasculitis, rheumatoid lung disease,
pericarditis, and pleuritis) are more frequent in patients
with rheumatoid nodules1. Severe ExRA has been as-
sociated with an increased mortality compared with pa-
tients with RA in general2.
A 83-year-old woman, followed in the outpatients
clinic, with a 20-year history of seropositive RA charac -
terized by systemic involvement including cutaneous
and pleuro-pulmonary rheumatoid nodules, scleroma-
laciaperforans, and rheumatoid vasculitis associated
with multi-organs failure, presented cough, hemopty-
sis, and weight loss. Due to the persistency of these
clini cal manifestations she was hospitalized and
diagnos tic workup, including [18F]FDG-PET/CT was
performed. PET/CT showed several areas of [18F]FDG
uptake (orbit, nasopharingx, lymph nodes, pleura,
lung, stomach, bowel, and joints). [18F]FDG-PET/CT
findings were consistent with ExRA manifestations as
confirmed by pleural biopsy.
In RA [18F]FDG-PET/CT has been mainly used to
assess joint(s) involvement or to evaluate metabolism
in lung nodule(s). Due to the association between RA
and systemic chronic inflammation, [18F]FDG scan
provides a non-invasive, quantitative method to study
the metabolic activity of target tissue, in vivo, which
can identify site(s) of active RA inflammation with high-
er sensitivity compared to clinical assessment3.
In conclusion, [18F]FDG-PET/CT may be used to
assess joints disease activity as well as ExRA manifesta-
tions.
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FIGURE 1. The maximum intensity projection (MIP) image (a)
shows several areas of high [18F]FDG uptake in orbit,
pharynx, lymph nodes, pleura, lungs, stomach, bowel, and
joints as confirmed by fused axial images (b: pleura
thickenings/lungs; c: left orbit; d: lymph nodes; e: joints)
